Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
McKinsey
Harvard Business School
Baxter
Mallinckrodt

Last Updated: September 26, 2022

Investigational Drug Information for Genexol-PM


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Genexol-PM?

Genexol-PM is an investigational drug.

There have been 18 clinical trials for Genexol-PM. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2009.

The most common disease conditions in clinical trials are Breast Neoplasms, Ovarian Neoplasms, and Carcinoma, Ovarian Epithelial. The leading clinical trial sponsors are Samyang Biopharmaceuticals Corporation, Gachon University Gil Medical Center, and Asan Medical Center.

Recent Clinical Trials for Genexol-PM
TitleSponsorPhase
A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of SorafenibGachon University Gil Medical CenterPhase 2
Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic CancerSamyang Biopharmaceuticals CorporationPhase 1
Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the PancreasSamyang Biopharmaceuticals CorporationPhase 2

See all Genexol-PM clinical trials

Clinical Trial Summary for Genexol-PM

Top disease conditions for Genexol-PM
Top clinical trial sponsors for Genexol-PM

See all Genexol-PM clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
McKinsey
Harvard Business School
Baxter
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.